Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03139916
Title Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Massachusetts General Hospital
Indications

gliosarcoma

glioblastoma

Therapies

Bavituximab + Temozolomide

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST